This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Heini Ilves: Innovator in HIV-1 Research
Introduction
Heini Ilves is a prominent inventor based in Palo Alto, California. She has made significant contributions to the field of HIV research, particularly in the development of innovative treatments. Her work focuses on the inhibition of HIV-1 replication, showcasing her dedication to advancing medical science.
Latest Patents
Heini Ilves holds a patent titled "Inhibition of HIV-1 replication by antisense RNA expression." This patent involves novel antisense sequences targeting the unspliced or single-spliced portions of mRNA transcripts from the HIV-1 provirus. The invention is designed to be co-expressed with an inhibitory transdominant mutant HIV-1 protein, which is useful in the treatment of HIV-1 infection. She has 1 patent to her name.
Career Highlights
Heini Ilves is associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in HIV treatment.
Collaborations
Throughout her career, Heini has worked alongside notable colleagues such as Ernst Boehnlein and Gabor Veres. These collaborations have further enhanced her research and innovation in the field of HIV.
Conclusion
Heini Ilves is a remarkable inventor whose work in HIV-1 research has the potential to impact countless lives. Her innovative approach and dedication to science exemplify the spirit of invention in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile